1. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial. Issue 5 (May 2021) Authors: Behr, Jürgen; Prasse, Antje; Kreuter, Michael; Johow, Johannes; Rabe, Klaus F; Bonella, Francesco; Bonnet, Reiner; Grohe, Christian; Held, Matthias; Wilkens, Heinrike; Hammerl, Peter; Koschel, Dirk; Blaas, Stefan; Wirtz, Hubert; Ficker, Joachim H; Neumeister, Wolfgang; Schönfeld, Nicolas; Clausse... Journal: Lancet Issue: Volume 9:Issue 5(2021) Page Start: 476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗